Onxeo SA (C4X.PA)
Get access to over 18 million research reports from over 1,700 sources.
For several years, Reuters.com has provided analyst research reports for downloading. In an effort to streamline our website, analyst research will now be available from our dedicated page for Thomson Reuters On Demand, and the Reuters service will discontinue as of September 30, 2016.
Thomson Reuters On Demand provides over 18 million research reports from 1,700 sources.
Moreover, Thomson Reuters On Demand offers fast and cost-effective solutions that would allow you to retrieve information on:
- private equity
- third-party document and information retrieval
- and much, much more…
Click here to request a report and the team of expert analysts will get back to you shortly, to ensure you get the report you need.
|54||2016||Non-Executive Chairman of the Board|
|44||2011||Chief Executive Officer, Member of the Executive Committee, Member of the Board|
|41||Vice President, Chief Financial Officer, Member of the Executive Committee|
|59||2016||Executive Vice President and Chief of U.S. Operations|
|2017||Chief Scientific Officer, Member of the Executive Committee|
- BRIEF-Onxeo reports commercial court of Paris decision in lawsuit against SpeBio/SpePharm
- BRIEF-Onxeo introduces chemistry platform of decoy oligonucleotides platON
- BRIEF-Onxeo announces preclinical data for combination of AsiDNA™ and belinostat
- BRIEF-Onxeo grants exclusive worldwide license for Validive to Monopar Therapeutics
- BRIEF-Onxeo announces top-line results from ReLive Phase III study of Livatag in advanced hepatocellular carcinoma